全文获取类型
收费全文 | 4155篇 |
免费 | 333篇 |
国内免费 | 29篇 |
专业分类
耳鼻咽喉 | 28篇 |
儿科学 | 140篇 |
妇产科学 | 176篇 |
基础医学 | 562篇 |
口腔科学 | 198篇 |
临床医学 | 445篇 |
内科学 | 808篇 |
皮肤病学 | 194篇 |
神经病学 | 287篇 |
特种医学 | 95篇 |
外科学 | 378篇 |
综合类 | 65篇 |
一般理论 | 7篇 |
预防医学 | 351篇 |
眼科学 | 81篇 |
药学 | 332篇 |
中国医学 | 47篇 |
肿瘤学 | 323篇 |
出版年
2024年 | 9篇 |
2023年 | 104篇 |
2022年 | 198篇 |
2021年 | 312篇 |
2020年 | 201篇 |
2019年 | 305篇 |
2018年 | 340篇 |
2017年 | 213篇 |
2016年 | 211篇 |
2015年 | 214篇 |
2014年 | 260篇 |
2013年 | 286篇 |
2012年 | 407篇 |
2011年 | 377篇 |
2010年 | 162篇 |
2009年 | 127篇 |
2008年 | 185篇 |
2007年 | 156篇 |
2006年 | 131篇 |
2005年 | 90篇 |
2004年 | 79篇 |
2003年 | 53篇 |
2002年 | 59篇 |
2001年 | 8篇 |
2000年 | 1篇 |
1999年 | 8篇 |
1998年 | 4篇 |
1997年 | 3篇 |
1996年 | 1篇 |
1995年 | 1篇 |
1994年 | 1篇 |
1993年 | 4篇 |
1992年 | 1篇 |
1989年 | 4篇 |
1988年 | 1篇 |
1965年 | 1篇 |
排序方式: 共有4517条查询结果,搜索用时 0 毫秒
91.
92.
Luca D'Onofrio Alise Kalteniece Maryam Ferdousi Shazli Azmi Ioannis N. Petropoulos Georgios Ponirakis Uazman Alam Omar Asghar Andrew Marshall Andrew J M. Boulton Nathan Efron Raffaella Buzzetti Handrean Soran Rayaz A. Malik 《Investigative ophthalmology & visual science》2021,62(6)
PurposeIncreased corneal and epidermal Langerhans cells (LCs) have been reported in patients with diabetic neuropathy. The aim of this study was to quantify the density of LCs in relation to corneal nerve morphology and the presence of diabetic neuropathy and to determine if this differed in patients with type 1 diabetes mellitus (T1DM), type 2 diabetes mellitus (T2DM), and latent autoimmune diabetes of adults (LADA).MethodsPatients with T1DM (n = 25), T2DM (n = 36), or LADA (n = 23) and control subjects (n = 23) underwent detailed assessment of peripheral neuropathy and corneal confocal microscopy. Corneal nerve fiber density (CNFD), branch density (CNBD), length (CNFL) and total, immature and mature LC densities were quantified.ResultsLower CNFD (P < 0.001), CNBD (P < 0.0001), and CNFL (P < 0.0001) and higher LC density (P = 0.03) were detected in patients with T1DM, T2DM, and LADA compared to controls. CNBD was inversely correlated with mature (r = –0.5; P = 0.008), immature (r = –0.4; P = 0.02) and total (r = –0.5; P = 0.01) LC density, and CNFL was inversely correlated with immature LC density (r = –0.4; P = 0.03) in patients with T1DM but not in patients with T2DM and LADA.ConclusionsThis study shows significant corneal nerve loss and an increase in LC density in patients with T1DM, T2DM, and LADA. Furthermore, increased LC density correlated with corneal nerve loss in patients with T1DM. 相似文献
93.
Ghaderi Maryam Sharifi Arash Jafarzadeh Pour Ebrahim 《International ophthalmology》2021,41(12):3935-3948
International Ophthalmology - The present study was done to evaluate efficiency of an ensemble learning structure for automatic keratoconus diagnosis and to categorize eyes into four different... 相似文献
94.
95.
Maryam Afkarian Michael C. Sachs Bryan Kestenbaum Irl B. Hirsch Katherine R. Tuttle Jonathan Himmelfarb Ian H. de Boer 《Journal of the American Society of Nephrology : JASN》2013,24(2):302-308
Type 2 diabetes associates with increased risk of mortality, but how kidney disease contributes to this mortality risk among individuals with type 2 diabetes is not completely understood. Here, we examined 10-year cumulative mortality by diabetes and kidney disease status for 15,046 participants in the Third National Health and Nutrition Examination Survey (NHANES III) by linking baseline data from NHANES III with the National Death Index. Kidney disease, defined as urinary albumin/creatinine ratio ≥30 mg/g and/or estimated GFR ≤60 ml/min per 1.73 m2, was present in 9.4% and 42.3% of individuals without and with type 2 diabetes, respectively. Among people without diabetes or kidney disease (reference group), 10-year cumulative all-cause mortality was 7.7% (95% confidence interval [95% CI], 7.0%–8.3%), standardized to population age, sex, and race. Among individuals with diabetes but without kidney disease, standardized mortality was 11.5% (95% CI, 7.9%–15.2%), representing an absolute risk difference with the reference group of 3.9% (95% CI, 0.1%–7.7%), adjusted for demographics, and 3.4% (95% CI, −0.3% to 7.0%) when further adjusted for smoking, BP, and cholesterol. Among individuals with both diabetes and kidney disease, standardized mortality was 31.1% (95% CI, 24.7%–37.5%), representing an absolute risk difference with the reference group of 23.4% (95% CI, 17.0%–29.9%), adjusted for demographics, and 23.4% (95% CI, 17.2%–29.6%) when further adjusted. We observed similar patterns for cardiovascular and noncardiovascular mortality. In conclusion, those with kidney disease predominantly account for the increased mortality observed in type 2 diabetes.In 2012, there were an estimated 346 million individuals with diabetes worldwide.1 This number is expected to rise to >430 million by 2030.2 Diabetes is associated with substantially increased risk of mortality, particularly due to cardiovascular disease.3Kidney disease, defined by increased urine albumin excretion and/or impaired GFR, is also strongly associated with increased risk of all-cause and cardiovascular mortality, both among persons with diabetes4,5 and in the general population.6–10 The critical effect of kidney disease on mortality in type 1 diabetes was emphasized in two recent reports.11,12 Each study demonstrated that excess mortality was confined to the subgroup with kidney disease.The degree to which kidney disease captures risk of adverse health outcomes in type 2 diabetes has not been determined. The findings from type 1 diabetes may not extrapolate to type 2 diabetes because the latter is frequently associated with other comorbidities that affect mortality. This question has crucial public health implications because type 2 diabetes predominates among the 26 million US adults with diabetes13,14 and identifying predictors of excess mortality in type 2 diabetes is essential in order to optimally target risk-reduction strategies. The primary objective of this study was to quantify and compare the excess risk of all-cause and cause-specific mortality among individuals with type 2 diabetes in presence or absence of kidney disease. 相似文献
96.
Masoumeh Sadeghi Arash Shahravan Ali Akbar Haghdoost Saeed Asgary Maryam Rad 《International dental journal》2012,62(2):84
Introduction: The number of scientific papers is a conventional metric for the measurement of a country’s research performance in a particular area. Objective: To evaluate the trend in Iranian publications of dental research results in peer-reviewed international scientific journals over the period 1999–2009, using national and international databases, and to compare the results with other countries. Methods: The search process was performed by two independent persons in PubMed and Iranian Medline (IranMedex). Data extraction included the year of publication, total number of dental papers in each year, total number of Iranian dental papers in each year and number of papers with a high level of evidence; these were compared with those in other Asian countries. Results: The total number of dental articles indexed in PubMed during the studied period was 207,689, with 671 being written by researchers who stated their affiliation as Iran. Although the proportion of Iranian dental articles to all published dental articles was 0.01% in 1990, this increased to 1.4% in 2009. Of all clinical trials indexed in PubMed from 1990 to 2009, only 0.62% had an author from Iran. The collaboration rate of authors ranged between 1 and 10. Turkey and Iran had a larger number of dental research publications compared with other Asian countries assessed in this study. Conclusion: During the last two decades, there has been a considerable increase in the number of dental papers by Iranian researchers indexed in the PubMed database.Key words: Dental, research, Iran 相似文献
97.
Naser Sharafaddinzadeh Ali Moghtaderi Nastaran Majdinasab Maryam Dahmardeh Davood Kashipazha Bita Shalbafan 《Clinical neurology and neurosurgery》2013
Background
Based on previous studies, Iran is located in a low risk area in terms of multiple sclerosis (MS). The objective of this study was to determine and compare the incidence, prevalence and demographic characteristics of MS in two ethnic groups of Persian and Arab over the period spanning 2009 in the Khuzestan province, in the Southwest of Iran.Methods
A cross-sectional case register study was conducted between January and August 2009. All cases in the region whom were referred to the MS society in the city of Ahwaz were participants in the study. The population data from the Iranian Bureau of Statistics were used to calculate the population at risk based on the 1996 and 2006 census data.Results
A total of 696 patients were identified according to the McDonald criteria during the last 12 years of which 569 patients were Persian. In 2009 the total prevalence and incidence rates of MS were 16.28 and 2.20 per 100,000 individuals. Based on these values, the female to male ratios were 3.11. The Persians manifested more sensory signs and symptoms (40.2%) but motor deficits (19.1%) and cerebellar findings (18.2%) were seen as being more manifest in Arab individuals. The main difference was observed in the progressive types of MS in which 24.7% of the Arab patients showed progressive type symptoms as compared to 15.9% of the cases in the Persian population.Conclusion
According to this study the authors conclude that the prevalence and incidence of MS were higher in Persians; however progressive forms of MS with motor and cerebellar signs are more frequent in the Arab ethnic group. 相似文献98.
Keivan Basiri Katsiaryna Belaya Wei Wei Liu Susan Maxwell Maryam Sedghi David Beeson 《Neuromuscular disorders : NMD》2013,23(6):469-472
Mutations in DPAGT1 are a newly recognised cause of congenital myasthenic syndrome. DPAGT1 encodes an early component of the N-linked glycosylation pathway. Initially mutations in DPAGT1 have been associated with the onset of the severe multisystem disorder – congenital disorder of glycosylation type 1J. However, recently it was established that certain mutations in this gene can cause symptoms restricted to muscle weakness resulting from defective neuromuscular transmission. We report four cases from a large Iranian pedigree with prominent limb-girdle weakness and minimal craniobulbar symptoms who harbour a novel mutation in DPAGT1, c.652C>T, p.Arg218Trp. This myasthenic syndrome may mimic myopathic disorders and is likely under-diagnosed. 相似文献
99.
100.
Carbon dioxide (CO2) is a greenhouse gas whose presence in the atmosphere significantly contributes to climate change. Developing sustainable, cost-effective pathways to convert CO2 into higher value chemicals is essential to curb its atmospheric presence. Electrochemical CO2 reduction to value-added chemicals using molecular catalysis currently attracts a lot of attention, since it provides an efficient and promising way to increase CO2 utilization. Introducing amino groups as substituents to molecular catalysts is a promising approach towards improving capture and reduction of CO2. This review explores recently developed state-of-the-art molecular catalysts with a focus on heterogeneous and homogeneous amine molecular catalysts for electroreduction of CO2. The relationship between the structural properties of the molecular catalysts and CO2 electroreduction will be highlighted in this review. We will also discuss recent advances in the heterogeneous field by examining different immobilization techniques and their relation with molecular structure and conductive effects.Electroreduction of CO2 to CO using molecular catalysis. 相似文献